Patel Priti's Form 4 filing
Neurogene Inc. (NGNE) · filed May 3, 2022
- Accession no.
- 0001209191-22-026894
- Filed
- May 3, 2022
- Trade date
- Apr 30-May 2, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.76K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel PritiCIK 0001859997 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $0.00 | $0 | 12,000 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −5,538 | $1.22 | −$6,756.36 | 6,462 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $0.00 | $0 | 10,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.